Effects of Preoperative Frailty on Postoperative Recovery
NCT ID: NCT06185270
Last Updated: 2023-12-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
139 participants
OBSERVATIONAL
2023-12-26
2024-12-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients undergoing minimally invasive distal gastrectomy for early gastric cancer
SPPB
Short Physical Performance Battery using the automated device (Andantefit)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SPPB
Short Physical Performance Battery using the automated device (Andantefit)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients who have a major medical or mental disease that can affect treatment outcome
* Patients unsuitable for this clinical trail on the opinion of researcher
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2308-179-1462
Identifier Type: -
Identifier Source: org_study_id